Imlifidase Terminated Phase 2 Trials for Thrombotic Thrombocytopenic Purpura (TTP) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02854059IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients